This is an outdated version published on 28-08-2017. Read the most recent version.

DEVELOPMENT AND VALIDATION OF AN ECOLOGICAL, NEW AND RAPID STABILITY-INDICATING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY FOR QUANTITATIVE DETERMINATION OF AZTREONAM IN LYOPHILIZED POWDER FOR INJECTION

Authors

  • Andressa Leme Figueiredo Faculdade de Ciências Farmacêuticas da Universidade Estadual Paulista; Brazil
  • Ana Carolina Kogawa Faculdade de Ciências Farmacêuticas da Universidade Estadual Paulista; Brazil
  • Hérida Regina Nunes Salgado Universidade Estadual Paulista http://orcid.org/0000-0002-0385-340X

DOI:

https://doi.org/10.22456/2527-2616.73755

Keywords:

aztreonam, analytical methods, HPLC, quality control, validation

Abstract

Aztreonam is a monocyclic synthetic antimicrobial with bactericidal activity against Gram-negative bacteria, the first agent from the monobactam family to be therapeutically approved. It was developed and validated analytical method using high performance liquid chromatography with UV detection at 292 nm to quantify the aztreonam. Furthermore, assessing stability through stress tests was carried out. The chromatographic separation was carried out by reverse phase on an Agilent C18 column (250 x 4.6 mm, 5 µm) with a mobile phase composed of water:ethanol (70:30, v/v) adjusted to pH 2.5 with acetic acid, pumped isocratically at a flow rate of 0.5 mL/min. The validation parameters linearity, selectivity, precision, accuracy, robustness, limits of detection and quantification were determined. The method proposed provides linear response within the concentration range of 45-95 µg/mL for aztreonam. Results obtained were found to be satisfactory. The proposed method is linear, accurate, precise, selective, and robust being able to quantify the aztreonam in raw material and in pharmaceutical preparations. The validated method was suitable for applications in quality control laboratories.

Downloads

Download data is not yet available.

Author Biography

Hérida Regina Nunes Salgado, Universidade Estadual Paulista

Departamento de Fármacos e Medicamentos

Faculdade de Ciências Farmacêuticas

Universidade Estadual Paulista

Rodovia Araraquara-Jau, km 1

CEP 14800-903

ARARAQUARA - SP

References

Srinivas, N.R., Papp, E.A., Shah, V.R., Shyo, W.C.

A simple HPLC assay, with ultraviolet detection, for

determination of a monobactam antibiotic. J Liquid

Chrom & Rel Technol. 1997; 20:1091-1101. DOI:

10.1080/10826079708010961.

US Pharmacopeia 37th, US Pharmacopeial

Convention, Rockville, 2014.

Georgopapadakou N.H., Smith S.A. and Sykes R.B.

Mode of action of azthreonam. J Pharm Biomed Anal,

1982;21:950–956.

Axelrod, J., Daly, J.S., Barza, M., Baker, A.S.

Antibacterials. In: Albert DM, Jakobiec FA, Ed.

Principles and practice of ophthalmology, Philadelphia,

W.B. Philadelphia; p.940-961, 1994.

Loeb, S. Physician’s drug handbook, 5th ed.

Springhouse Corporation: Springhouse; 1993.

Papich, M.G., Ettinger, S.J., Feldman, E.C.

Antimicrobial drugs. Textbook of veterinary internal

medicine, 4th edn WB Saunders Company:

Philadelphia; 1:272-274, 1995.

Sykes, R.B., Koster, W.H., Bonner, D.P. The new

monobactams: chemistry and biology. J. Clin.

Pharmacol. 1988; 28:113–119.

Kapoor, S., Gathwala, G. Aztreonam. Indian

Pediatrics, 2004;41:359–364.

Giamarellou, H., Galanakis, N., Douzinas, E.,

Petrikkos, G., El Messidi, M., Papoulias, G., Daikos,

G.K. Evaluation of aztreonam in difficult to treat

infections with prolonged post-treatment follow up.

Antimicrob Agents Chemother. 1984;26:245-249.

Swabb, E.A., Sugerman, A.A., Stern, M. Oral

bioavailability of the monobactam aztreonam (SQ

26,776) in healthy subjects. Antimicrob Agents

Chemother. 1983; 23:548-550.

Swabb, E.A. Review of the clinical pharmacology

of the monobactam antibiotic aztreonam. Am J Med.

78:11-18, 1985.

Davis, J.D. Aztreonam, Elsevier Science: New

York; 4:61-64, 1997.

Zajac, M., Jelinska, A., Cielecka-Piontek, J.,

Oszczapowicz, I. Stability of aztreonam in

AZACTAM. II Farmaco, 2005; 60:599-603. DOI

10.1016/j.farmac.2005.04.009.

Pilkiewick, F.G., Remsburg, B.J., Fisher, S.M.,

Sykes, R.B. High-pressure liquid chromatographic

analysis of aztreonam in serum and urine. Antimicrob

Agents Chemother. 1983;23:852-856.

Egger, H., Fischer, G. Determination of the

monocyclic beta-lactam antibiotic carumonam in

plasma and urine by ion-pair and ion-suppression

reversed-phase high-performance liquid

chromatography. J Chromatography, 1987;420:357-

372.

Ranadive, S.A., Pipkin, J.D., Varia, S.A., Chang,

N.H., Barry, E.P., Porubcan, M., et al. Formation,

isolation and identification of oligomers of aztreonam.

Eur J Pharm Sci, 1995;3:281-291.

ICH Q2 (R1). Validation of analytical procedures:

text and methodology, in Proceedings of the

International Conference on Harmonization, IFPMA,

Geneva, 2005.

Brasil, Agência Nacional de Vigilância Sanitária,

RE 899, Guia para validação de métodos analíticos e

bioanalíticos, Brasília, 2003.

Zivanovic, L., Zigic, G., Zecevic, M. Investigation

of chromatographic conditions for the separation of ofloxacin and its degradation products. J Chromatogr

A, 2006; 1119:224-230.

Lopes, C.C.G.O., Salgado, H.R.N. Development of

a validated stability-indicating LC assay and stress

degradation studies of linezolid in tablets.

Chromatographia, 2009; 69:S129–S135. DOI

10.1365/s10337-009-0993-3.

Cazedey, E.C.L., Perez, D.P., Perez, J.P., Salgado,

H.R.N. A high performance liquid chromatographic

assay for ciprofloxacin hydrochloride ophthalmic

solution. Chromatographia, 2009; 69:S241–S244. DOI

10.1365/s10337-009-1004-4.

FDA, Validation of chromatographic methods,

Center of Drug Evaluation and Research: Washington;

2004.

Inmetro DOQ-CGCRE-008, Orientação sobre

validação de métodos analíticos, 2011.

Brazilian Pharmacopeia, ANVISA: Brasília; 5th

edn, 2010.

Joshi, S. HPLC separation of antibiotics present in

formulated and unformulated samples. J Pharm

Biomed Anal, 2002; 28:795-809.

Karcher, B.D., Davies, M.L., Delaney, E.J., Vent,

J.J. A 21st Century HPLC workflow for process R&D.

JALA, 2005; 381-393.

Rugani, K.S., Salgado, H.R.N. Stability-indicating

LC method for the determination of cephalothin in

lyophilized powder for injection. Anal Meth, 2014;

6:4437-4445. DOI: 10.1039/C3AY42049C.

Bonfilio, R., Cazedey, E.C.L., Araújo, M.B.,

Salgado, H.R.N. Analytical validation of quantitative

high-performance liquid chromatographic methods in

pharmaceutical analysis: A practical approach. Crit

Rev Anal Chem, 2012;42:87–100.

http://dx.doi.org/10.1080/10408347.2012.630926

Pedroso, T.M., Medeiros, A.C.D., Salgado, H.R.N.

RP-HPLC x HILIC chromatography for quantifying

the ertapenem sodium with a look at green chemistry.

Talanta, 2016; 160:745–753.

http://dx.doi.org/10.1016/j.talanta.2016.08.016i

Gałuszka, A., Migaszewski, Z., Namies’nik, J. The

12 principles of green analytical chemistry and the

SIGNIFICANCE mnemonic of green analytical

practices. Trends Anal Chem. 2013; 50:78–84.

Salgado, H.R.N. New analytical methods for a new

awake society. EC Microbiol. 2017; 9(2)39.

Ribeiro, R.L.V., Bottoli, C.B.G., Collins,

K.E.,Collins, C.H. Reevaluation of ethanol as organic

modifier for use in HPLC-RP mobile phases. J Braz

Chem Soc. 2004; 15(2):300-306.

Ribeiro, R.L.V., Grespan, C.B., Collins, C.H.,

Collins, K.E., Bruns, R.E. Optimization through

factorial planning of the use of ethanol:water as a

mobile phase for reversed phase HPLC. J High Resolut

Chromatogr. 1999; 22(1): 52-54.

Miyabe, K., Takeuchi, S., Tezuka, Y. Adsorption

characteristics in reversed-phase liquid

chromatography using ethanol/water mixed solvent.

Adsorption, 1999; 5:15-24.

Moreno, A.H., Salgado, H.R.N. Development and

validation of HPLC method for determination of

ceftazidime. J AOAC Int., 2008; 91:739-743.

Vieira, D.C.M., Salgado, H.R.N. Comparison of

HPLC and UV spectrophotometric methods for the

determination of cefuroxime sodium in pharmaceutical

products. J Chromatogr Sci. 2011; 49:508-511.

Tótoli, E.G., Salgado, H.R.N. Development and

validation of an economic, environmental friendly and

stability-indicating analytical method for determination

of ampicillin sodium for injection by RP-HPLC. World

J Pharm Pharmac Sci. 2014; 3(6): 1928-1943.

Tótoli, E.G., Salgado, H.R.N. Development and

validation of an economic, environmental friendly and

stability-indicating analytical method for determination

of ampicillin sodium for injection by RP-HPLC. World

J Pharm Pharmac Sci. 2014; 3:1928-1943.

Tótoli, E.G., Salgado, H.R.N. Development,

optimization and validation of a green and stabilityindicating

HPLC method for determination of

daptomycin in lyophilized powder. J AOAC Int. 2015;

98:1276-1285.

Pedroso, T.M., Medeiros, A.C.D., Salgado, H.R.N.

RP-HPLC x HILIC chromatography for quantifying

the ertapenem sodium with a look at green chemistry.

Talanta, 2016; 160:745–753.

http://dx.doi.org/10.1016/j.talanta.2016.08.016i

Rodrigues, D.F., Salgado, H.R.N. Development

and validation of a green analytical method of RPHPLC

for quantification cefepime hydrochloride in

pharmaceutical dosage forms: simple, sensitive and

economic. Cur Pharm Anal. 2016; 12:306-314. Doi

10.2174/1573412912666151221210921.

Figueiredo, A.L., Salgado, H.R.N. Validation of a

green analytical method for the quantitative analysis

of antimicrobial aztreonam in lyophilized powder for

injection by Fourier-Transform Infrared Spectroscopy

(FT-IR). EC Microbiol. 2017; 8(5):254-265.

https://www.ecronicon.com/ecmi/pdf/ECMI-08-

00257.pdf

Figueiredo, A.L., Salgado, H.R.N. Development

and validation of a ultraviolet (UV)

spectrophotometric method for determination of

aztreonam in pharmaceutical products. EC Microbiol.

2017; 8(6):305-316.

Downloads

Published

28-08-2017 — Updated on 28-08-2017

Versions

How to Cite

Figueiredo, A. L., Kogawa, A. C., & Salgado, H. R. N. (2017). DEVELOPMENT AND VALIDATION OF AN ECOLOGICAL, NEW AND RAPID STABILITY-INDICATING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY FOR QUANTITATIVE DETERMINATION OF AZTREONAM IN LYOPHILIZED POWDER FOR INJECTION. Drug Analytical Research, 1(1), 24–30. https://doi.org/10.22456/2527-2616.73755

Issue

Section

ORIGINAL ARTICLES